Letter to the Editor
Response to: Sjögren's Syndrome and Halitosis: A Case Report
Respuesta a: Síndrome de Sjögren y halitosis: descripción de un caso clínico
Rami Qanneta
Servicio de Reumatología, Hospital Universitari Joan XXIII, Tarragona, Spain
Read
5528
Timeswas read the article
1996
Total PDF
3532
Total HTML
Share statistics
array:24 [ "pii" => "S2173574316300934" "issn" => "21735743" "doi" => "10.1016/j.reumae.2016.02.003" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "882" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "copyrightAnyo" => "2015" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2016;12:357-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 922 "formatos" => array:3 [ "EPUB" => 66 "HTML" => 591 "PDF" => 265 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1699258X16000309" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2016.02.001" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "882" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2016;12:357-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6893 "formatos" => array:3 [ "EPUB" => 167 "HTML" => 5815 "PDF" => 911 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Respuesta a: Síndrome de Sjögren y halitosis: descripción de un caso clínico" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "357" "paginaFinal" => "358" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Response to: Sjögren's syndrome and halitosis: A case report" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rami Qanneta" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Rami" "apellidos" => "Qanneta" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173574316300934" "doi" => "10.1016/j.reumae.2016.02.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574316300934?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16000309?idApp=UINPBA00004M" "url" => "/1699258X/0000001200000006/v1_201610280501/S1699258X16000309/v1_201610280501/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173574316300922" "issn" => "21735743" "doi" => "10.1016/j.reumae.2016.01.005" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "881" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2016;12:358-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1391 "formatos" => array:3 [ "EPUB" => 52 "HTML" => 975 "PDF" => 364 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "New Drugs in Takayasu Arteritis, Role of Tocilizumab" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "358" "paginaFinal" => "359" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Nuevos fármacos en la arteritis de Takayasu, papel del tocilizumab" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sonia Martín Guillén, Antonio Álvarez de Cienfuegos, Roberto Hurtado García" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Sonia" "apellidos" => "Martín Guillén" ] 1 => array:2 [ "nombre" => "Antonio" "apellidos" => "Álvarez de Cienfuegos" ] 2 => array:2 [ "nombre" => "Roberto" "apellidos" => "Hurtado García" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X16000292" "doi" => "10.1016/j.reuma.2016.01.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16000292?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574316300922?idApp=UINPBA00004M" "url" => "/21735743/0000001200000006/v1_201611050033/S2173574316300922/v1_201611050033/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173574316300946" "issn" => "21735743" "doi" => "10.1016/j.reumae.2016.02.004" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "891" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2016;12:356-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 948 "formatos" => array:3 [ "EPUB" => 60 "HTML" => 613 "PDF" => 275 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Vitamin D and Autoimmune Rheumatic Diseases" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "356" "paginaFinal" => "357" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Vitamina D y enfermedades reumáticas" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María A. Martín-Martínez, Santos Castañeda, Ana Urruticoechea-Arana, Miguel A. González-Gay" "autores" => array:4 [ 0 => array:2 [ "nombre" => "María A." "apellidos" => "Martín-Martínez" ] 1 => array:2 [ "nombre" => "Santos" "apellidos" => "Castañeda" ] 2 => array:2 [ "nombre" => "Ana" "apellidos" => "Urruticoechea-Arana" ] 3 => array:2 [ "nombre" => "Miguel A." "apellidos" => "González-Gay" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X16000401" "doi" => "10.1016/j.reuma.2016.02.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16000401?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574316300946?idApp=UINPBA00004M" "url" => "/21735743/0000001200000006/v1_201611050033/S2173574316300946/v1_201611050033/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Response to: Sjögren's Syndrome and Halitosis: A Case Report" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "357" "paginaFinal" => "358" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Rami Qanneta" "autores" => array:1 [ 0 => array:3 [ "nombre" => "Rami" "apellidos" => "Qanneta" "email" => array:1 [ 0 => "rami_kanita229@hotmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Reumatología, Hospital Universitari Joan XXIII, Tarragona, Spain" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta a: Síndrome de Sjögren y halitosis: descripción de un caso clínico" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Dear Editor</span>:</p><p id="par0010" class="elsevierStylePara elsevierViewall">I read very carefully the publication of Ruiz Serrato et al.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a> in <span class="elsevierStyleSmallCaps">Reumatología Clínica</span>, where the authors report a case of halitosis secondary to Sjögren's syndrome (SS). I would like to express a few considerations, which I hope will contribute to a better understanding of this association.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Sjögren's syndrome is a systemic, autoimmune disease, with a prevalence that ranges between 0.1% and 0.5%, with a predominance of women (4th and 5th decades of life).<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a> Histopathological studies show it to be characterized by lymphocytic infiltration at the level of the exocrine glands.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a> This syndrome can be primary or secondary (associated with systemic lupus erythematosus, rheumatic arthritis and scleroderma).<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a> The destruction of the exocrine glands leads to “sicca syndrome” (xerostomia and xerophthalmia).<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a> However, SS can show extraglandular manifestations, including general, cutaneous, musculoskeletal, respiratory, urogenital, thyroid, gastrointestinal and hepatobiliary.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a> The association between halitosis and SS is multifactorial.</p><p id="par0020" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">First:</span> Parotid gland dysfunction results in xerostomia and a decrease in salivary flow that leads to periodontal diseases due to <span class="elsevierStyleItalic">Treponema denticola, Porphyromonas gingivalis</span> and <span class="elsevierStyleItalic">Bacteroides forsythus</span>, which produce mercaptan and sulfur that are associated with the level of halitosis (oral cause of halitosis).<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a> Saliva has antimicrobial properties; thus, the amount and quality of saliva are essential to prevent halitosis. Therefore, in patients with SS and xerostomia, the production of saliva is reduced, increasing the possibility of generating volatile sulfur compounds (VSC), the result of the degradation of proteins with sulfur-containing amino acids from the exfoliation of human epithelial cells, leukocytes and the remains of food, and with it, oral malodor.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a> Volatile sulfur compounds are associated not only with halitosis, but can enter into a vicious circle of pathogenesis of gingivitis and periodontitis.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Second:</span> Extraglandular manifestations are factors that trigger halitosis in SS. Patients with SS are more predisposed to develop chronic rhinosinusitis (a perioral cause of halitosis) and bronchiectasis (an extraoral cause of halitosis). Among the gastrointestinal manifestations, they may present esophageal dysfunction, chronic gastritis, <span class="elsevierStyleItalic">Helicobacter pylori</span> infection and bacterial overgrowth, which also cause halitosis (extraoral cause). Primary biliary cirrhosis, as a hepatobiliary manifestation, is an extraoral cause of halitosis.</p><p id="par0030" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Third:</span> Diseases associated with secondary SS play their own role. For example, gastroesophageal reflux (an extraoral cause) in SS secondary to scleroderma produces dental erosion and dysphagia that provoke halitosis.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">4</span></a> Moreover, patients with SS have an elevated risk of developing non-Hodgkin's B-cell lymphoma, which can be an extraoral cause of halitosis. On the other hand, the symptomatology of halitosis in SS patients can, subjectively, be worse (not genuine), by psychosomatic halitosis, halitophobia or because the xerogenic medicine they take (antidepressant and nonsteroid anti-inflammation drugs). With respect to the case reported by Ruiz Serrato et al.,<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a> as the authors, reasonably explain, it is true halitosis due to oral causes (xerostomia), with a favorable response to pilocarpine. However, we recommend follow-up, to screen for possible perioral and/or extraoral causes related to SS, in the case of therapeutic failure or recurrence. I conclude that, halitosis is a prevalent entity (up to 50% of the general population), and has been studied little in SS. Although, it is considered more a problem related to poor dental hygiene or to diseases of the oral cavity (87%), on occasions, it may be a manifestation of the disease at other levels—perioral—or even of a psychiatric or systemic disease—extraoral—(13%).<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a> Therefore, an initial approximation should include a complete history (diet, drugs, poor habits and dental hygiene), a thorough examination, a complete analysis, as in screening. The therapeutic management requires a multidisciplinary evaluation, with hygienic, dietetic, pharmacological (pilocarpine hydrochloride) and/or etiological—oral, perioral, extraoral or mixed, as in the case of SS.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Qanneta R. Respuesta a: Síndrome de Sjögren y halitosis: descripción de un caso clínico. Reumatol Clin. 2016;12:357–358.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib0025" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "pii: S1699-258X(15)00191-6. [Epub ahead of print] http://dx.doi.org/10.1016/j.reuma.2015.11.005" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sjögren's syndrome and halitosis: a case report [Article in English, Spanish]" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Ruiz Serrato" 1 => "R. Infantes Ramos" 2 => "A. Jiménez Ríos" 3 => "P.P. Luján Godoy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.reuma.2015.11.005" "Revista" => array:2 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2015" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0030" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Primary Sjögren syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Ramos-Casals" 1 => "P. Brito-Zerón" 2 => "A. Sisó-Almirall" 3 => "X. Bosch" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Praxis (Bern 1994)" "fecha" => "2012" "volumen" => "101" "paginaInicial" => "1565" "paginaFinal" => "1571" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0035" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Halitosis – an overview: Part-I – Classification, etiology, and pathophysiology of halitosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "G.S. Madhushankari" 1 => "A. Yamunadevi" 2 => "M. Selvamani" 3 => "K.P. Mohan Kumar" 4 => "P.S. Basandi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4103/0975-7406.163441" "Revista" => array:7 [ "tituloSerie" => "J Pharm Bioallied Sci" "fecha" => "2015" "volumen" => "7" "numero" => "Suppl. 2" "paginaInicial" => "S339" "paginaFinal" => "S343" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26538874" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0040" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic sclerosis/scleroderma: a treatable multisystem disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Hinchcliff" 1 => "J. Varga" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am Fam Physician" "fecha" => "2008" "volumen" => "78" "paginaInicial" => "961" "paginaFinal" => "968" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001200000006/v1_201611050033/S2173574316300934/v1_201611050033/en/main.assets" "Apartado" => array:4 [ "identificador" => "8400" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001200000006/v1_201611050033/S2173574316300934/v1_201611050033/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574316300934?idApp=UINPBA00004M" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 22 | 12 | 34 |
| 2024 October | 158 | 41 | 199 |
| 2024 September | 165 | 8 | 173 |
| 2024 August | 160 | 35 | 195 |
| 2024 July | 135 | 25 | 160 |
| 2024 June | 105 | 30 | 135 |
| 2024 May | 103 | 30 | 133 |
| 2024 April | 92 | 20 | 112 |
| 2024 March | 58 | 29 | 87 |
| 2024 February | 41 | 29 | 70 |
| 2024 January | 55 | 18 | 73 |
| 2023 December | 56 | 24 | 80 |
| 2023 November | 42 | 31 | 73 |
| 2023 October | 54 | 34 | 88 |
| 2023 September | 45 | 30 | 75 |
| 2023 August | 30 | 26 | 56 |
| 2023 July | 40 | 22 | 62 |
| 2023 June | 32 | 22 | 54 |
| 2023 May | 41 | 23 | 64 |
| 2023 April | 26 | 13 | 39 |
| 2023 March | 54 | 30 | 84 |
| 2023 February | 38 | 31 | 69 |
| 2023 January | 58 | 31 | 89 |
| 2022 December | 68 | 45 | 113 |
| 2022 November | 61 | 28 | 89 |
| 2022 October | 67 | 29 | 96 |
| 2022 September | 36 | 31 | 67 |
| 2022 August | 36 | 47 | 83 |
| 2022 July | 43 | 38 | 81 |
| 2022 June | 35 | 30 | 65 |
| 2022 May | 49 | 56 | 105 |
| 2022 April | 29 | 36 | 65 |
| 2022 March | 44 | 37 | 81 |
| 2022 February | 36 | 28 | 64 |
| 2022 January | 48 | 36 | 84 |
| 2021 December | 25 | 39 | 64 |
| 2021 November | 43 | 44 | 87 |
| 2021 October | 50 | 52 | 102 |
| 2021 September | 50 | 40 | 90 |
| 2021 August | 31 | 48 | 79 |
| 2021 July | 26 | 36 | 62 |
| 2021 June | 29 | 31 | 60 |
| 2021 May | 46 | 34 | 80 |
| 2021 April | 67 | 92 | 159 |
| 2021 March | 58 | 27 | 85 |
| 2021 February | 35 | 24 | 59 |
| 2021 January | 30 | 23 | 53 |
| 2020 December | 41 | 32 | 73 |
| 2020 November | 28 | 23 | 51 |
| 2020 October | 23 | 16 | 39 |
| 2020 September | 42 | 24 | 66 |
| 2020 August | 35 | 19 | 54 |
| 2020 July | 21 | 19 | 40 |
| 2020 June | 39 | 23 | 62 |
| 2020 May | 21 | 14 | 35 |
| 2020 April | 20 | 29 | 49 |
| 2020 March | 19 | 7 | 26 |
| 2020 February | 1 | 0 | 1 |
| 2019 May | 0 | 1 | 1 |
| 2018 December | 2 | 0 | 2 |
| 2018 May | 3 | 3 | 6 |
| 2018 April | 34 | 3 | 37 |
| 2018 March | 54 | 6 | 60 |
| 2018 February | 28 | 6 | 34 |
| 2018 January | 22 | 3 | 25 |
| 2017 December | 18 | 5 | 23 |
| 2017 November | 20 | 10 | 30 |
| 2017 October | 15 | 5 | 20 |
| 2017 September | 25 | 15 | 40 |
| 2017 August | 24 | 7 | 31 |
| 2017 July | 26 | 14 | 40 |
| 2017 June | 36 | 15 | 51 |
| 2017 May | 38 | 19 | 57 |
| 2017 April | 35 | 17 | 52 |
| 2017 March | 27 | 23 | 50 |
| 2017 February | 23 | 5 | 28 |
| 2017 January | 48 | 25 | 73 |
| 2016 December | 58 | 40 | 98 |
| 2016 November | 50 | 38 | 88 |
| 2016 October | 4 | 5 | 9 |
Show all
